Feb 14, 2024 · The Ionis Pharmaceuticals stock price gained 0.95% on the last trading day (Wednesday, 14th Feb 2024), rising from $48.61 to $49.07. During the last trading day the stock fluctuated 1.88% from a day low at $48.41 to a day high of $49.32. The price has fallen in 6 of the last 10 days and is down by -4.51% for this period. Feb 15, 2024 · Summary of all time highs, changes and price drops for Ionis Pharmaceuticals; Historical stock prices; Current Share Price: US$44.43: 52 Week High: US$54.44: 52 Week Low: Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced positive topline results for the Phase 3 OASIS-HAE study of donidalorsen in people with hereditary angioedema (HAE). The trial met its primary endpoint of reduction in rate of angioedema attacks in patients treated with donidalorsen (80mg) via subcutaneous injection dosed every 4 weeks …The initial conversion price represents a premium of approximately 32.5% over the last reported sale price of $40.55 per share of Ionis' common stock on June 7, 2023.Ionis Pharmaceuticals, Inc. reported strong Q4 earnings with a 34% YoY revenue increase. The stock price is down, is IONS a buy? Click for my IONS earnings …Find the latest Ionis Pharmaceuticals, Inc. (IONS) stock quote, history, news and other vital information to help you with your stock trading and investing.Price T Rowe Associates Inc. MD now owns 4,255,074 shares of the company's stock valued at $215,265,000 after buying an additional 497,077 shares during the last quarter. Finally, BVF Inc. IL boosted its position in shares of Ionis Pharmaceuticals by 11.1% during the second quarter.Jan 23, 2024 · Zacks Rank & A Key Pick. Ionis currently carries a Zacks Rank #2 (Buy). A better-ranked stock in the overall healthcare sector is CytomX Therapeutics (CTMX Quick Quote CTMX - Free Report) , which ... Ionis Pharmaceuticals, Inc. (IONS) Stock Price, News, Quote & History - Yahoo Finance Canada Markets close in 4 hrs 34 mins S&P/TSX 20,818.77 -150.41(-0.72%) S&P 500 …Dec 19, 2012 · A high-level overview of Ionis Pharmaceuticals, Inc. (IONS) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Aug 24, 2017 ... TRC's offer price of $44.88 per share is about 4.47% lower than the $46.98 closing share price of Ionis' common stock on August 18, the business ...... stock price by the number of shares outstanding. Ionis Pharmaceuticals market cap as of February 13, 2024 is $6.97B. Compare IONS With Other Stocks. Sector ...Stock prices are delayed, the delay can range from a few minutes to several hours. Company logos are from the CompaniesLogo.com logo database and belong to ...5 days ago ... ... stock price last year when shares rose 125%. A rough start to 2024 means the stock is still floundering at levels far below where it traded ...Ionis Pharmaceuticals stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.comFind out before anyone else which stock is going to shoot up. Get powerful stock screeners & detailed portfolio analysis. Subscribe Now See Plans & Pricing. Ionis Pharmaceuticals (IONS) last ex-dividend date was on ―. Ionis Pharmaceuticals distributed ― per share that represents a ― dividend yield.Dec 7, 2023 ... Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. ... Stock Analysis. THOR ...IONS Stock 12 Months Forecast. $59.92. (21.32% Upside) Based on 12 Wall Street analysts offering 12 month price targets for Ionis Pharmaceuticals in the last 3 months. The average price target is $59.92 with a high forecast of $85.00 and a low forecast of $37.00. The average price target represents a 21.32% change from the last price of $49.39.CARLSBAD, Calif., May 8, 2013 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today the pricing of an underwritten public offering of 9,000,000 shares of its common stock, offered at a price to the public of $19.00 per share. The gross proceeds to Isis from this offering are expected to be $171.0 million, before deducting the underwriting …4 days ago · Ionis Pharmaceuticals Insider Sold Shares Worth $1,160,303, According to a Recent SEC Filing. Feb. 05. MT. JPMorgan Chase Adjusts Price Target on Ionis Pharmaceuticals to $55 From $52, Maintains Neutral Rating. Feb. 01. MT. Ionis Pharmaceuticals Insider Sold Shares Worth $333,788, According to a Recent SEC Filing. Since its IPO on the Shenzhen stock exchange, its share price has gone up every day by the exact same amount. Baofeng Technologies is China’s best performing stock this year. Since...Oct 9, 2023 ... Ionis Pharmaceuticals, Inc. If approved, this would be the first FDA-approved treatment for the disease and Ionis's first independent drug ...Stock analysis for Ionis Pharmaceuticals Inc (ISIP:US) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Jun 8, 2023 ... The conversion rate for the notes will initially be 18.6120 shares of Ionis' common stock per $1,000 principal amount of notes (equivalent to an ...Price Targets: Gaining insights, analysts provide estimates for the future value of Ionis Pharmaceuticals's stock. This comparison reveals trends in analysts' expectations over time.Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced positive topline results for the Phase 3 OASIS-HAE study of donidalorsen in people with hereditary angioedema (HAE). The trial met its primary endpoint of reduction in rate of angioedema attacks in patients treated with donidalorsen (80mg) via subcutaneous injection dosed every 4 weeks …Under the terms of the collaboration, Biogen will pay Ionis $1 billion in cash, which will include $625 million to purchase 11,501,153 shares of Ionis common stock at a price of $54.34 per share, at an approximately 25% cash premium, and a $375 million upfront payment.Stock analysis for Ionis Pharmaceuticals Inc (IONS:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Find the latest Puma Biotechnology, Inc. (PBYI) stock quote, history, news and other vital information to help you with your stock trading and investing.With a price-to-earnings ratio of -19.60 and a beta of 0.51, its performance reflects some level of volatility in comparison to other equities. Notably, Ionis Pharmaceuticals has experienced fluctuations in its stock price throughout the past year as its value dropped to $32.69 before reaching its highest point at $47.74.Find the latest Ionis Pharmaceuticals, Inc. (IONS) stock discussion in Yahoo Finance's forum. ... NasdaqGS - NasdaqGS Real Time Price. Currency in USD. Follow. Visitors trend 2W 10W 9M. 44.43-0.85 ...The stock was sold at an average price of $49.54, for a total value of $105,272.50. ... Stifel Nicolaus increased their price target on Ionis Pharmaceuticals …Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced positive topline results for the Phase 3 OASIS-HAE study of donidalorsen in people with hereditary angioedema (HAE). The trial met its primary endpoint of reduction in rate of angioedema attacks in patients treated with donidalorsen (80mg) via subcutaneous injection dosed every 4 weeks …Ionis Pharmaceuticals Inc stock price (IONS) NASDAQ: IONS. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Ionis Pharmaceuticals Inc stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting. Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins an...Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced positive topline results for the Phase 3 OASIS-HAE study of donidalorsen in people with hereditary angioedema (HAE). The trial met its primary endpoint of reduction in rate of angioedema attacks in patients treated with donidalorsen (80mg) via subcutaneous injection dosed every 4 weeks …Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past...The three major U.S. stock exchanges are the New York Stock Exchange (NYSE), the NASDAQ and the American Stock Exchange (AMEX). As of 2014, the NYSE is the largest and most prestig...Ionis’ stock has risen 18.8% in the past year against a decrease of 5.2% for the industry. Zacks Investment Research. Image Source: ... Ionis Pharmaceuticals, Inc. Price and Consensus.Ionis Pharmaceuticals Stock Forecast, IONS stock price prediction. Price target in 14 days: 53.455 USD. The best long-term & short-term Ionis ...Complete Ionis Pharmaceuticals Inc. stock information by Barron's. View real-time IONS stock price and news, along with industry-best analysis. Ionis Pharmaceuticals stock price forecast* for tomorrow, and next weeks based on the last 30 days [60% OFF VIP SALE] Portfolio is UP +117% in 2023 - Try Now Risk-Free - Money-back guarantee! IONS forecast for the upcoming days Date Price Min Price Max Price; 2024-01-18: Price: 50.878: Min: 49.788: Max: ...About the Ionis Pharmaceuticals, Inc. stock forecast. As of 2024 February 19, Monday current price of IONS stock is 44.430$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception).. Ionis Pharmaceuticals stock price as been showing a rising tendency so we believe that …This price is significantly higher than the GuruFocus Value of $33.21, suggesting that the stock is overvalued. Insider Sell: EVP, Chief Scientific Officer C Bennett Sells 4,460 Shares of Ionis ...IONS Stock 12 Months Forecast. $59.92. (21.32% Upside) Based on 12 Wall Street analysts offering 12 month price targets for Ionis Pharmaceuticals in the last 3 months. The average price target is $59.92 with a high forecast of $85.00 and a low forecast of $37.00. The average price target represents a 21.32% change from the last price of $49.39. Tax, title and license extra. $7,500 EV Bonus available as EV Bonus Cash or EV Lease Bonus. $7,500 EV Bonus Cash available on new 2024 IONIQ 5 vehicles purchased from retailer stock. $7,500 EV Lease Bonus available to well-qualified lessees of new 2024 IONIQ 5 vehicles leased from retailer stock. $7,500 EV Lease Bonus valid only when leased ... IONS Stock 12 Months Forecast. $59.92. (21.32% Upside) Based on 12 Wall Street analysts offering 12 month price targets for Ionis Pharmaceuticals in the last 3 months. The average price target is $59.92 with a high forecast of $85.00 and a low forecast of $37.00. The average price target represents a 21.32% change from the last price of $49.39. If yes, then on this page you will find useful information about the dynamics of the IONS stock price in 2022-2027. Is IONS a good long term stock? When should I take profit in ... Close Price: Change: Ionis Pharmaceuticals Stock Forecast for 2023: January 2023: 24: 22.22-7.42% : February 2023: 21.78: 22: 1.01% : March 2023: 22.22: ...Stock Price, News, Quote and Profile of IONIS PHARMACEUTICALS INC(NASDAQ:IONS) stock. General stock ratings, overview and activity description.TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.com7 days ago ... ... price. In the last year Ionis Pharmaceuticals insiders didn't buy any company stock. You can see a visual depiction of insider transactions ...While the top- and bottom-line numbers for Ionis Pharmaceuticals ... The stock currently has a Zacks Rank ... it would cost him roughly $450 million. In a post on X, formerly Twitter, Grant ...Ionis Pharmaceuticals Inc stock price (IONS) NASDAQ: IONS. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Ionis Pharmaceuticals Inc stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting.If you need cash, aren’t happy with your investment returns or want to diversify your investments, you may have to liquidate some of your stocks. Buying and selling stocks is extre...Biliouris covers the Healthcare sector, focusing on stocks such as Alnylam Pharma, Ionis Pharmaceuticals, ... Wells Fargo also maintained a Buy rating on the stock with a $85.00 price target.Dec 19, 2012 · A high-level overview of Ionis Pharmaceuticals, Inc. (IONS) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Find the latest Ionis Pharmaceuticals, Inc. (IONS) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. Ionis (IONS) incurs a narrower-than-expected fourth-quarter loss. ... Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, ...With a price-to-earnings ratio of -19.60 and a beta of 0.51, its performance reflects some level of volatility in comparison to other equities. Notably, Ionis Pharmaceuticals has experienced fluctuations in its stock price throughout the past year as its value dropped to $32.69 before reaching its highest point at $47.74.Dec 22, 2023 · Ionis Pharmaceuticals, Inc. price-consensus-chart | Ionis Pharmaceuticals, Inc. Quote Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the ... Get the latest Ionis Pharmaceuticals Inc (IONS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and …Currently, Ionis Pharmaceuticals Inc does not have a price-earnings ratio. Ionis Pharmaceuticals Inc’s trailing 12-month revenue is $615.0 million with a -66.6% net profit margin. ... Momentum is based on the price change of a stock over a specified period relative to all other stocks.Feb 2, 2024 · Piper Sandler Adjusts Ionis Pharmaceuticals' Price Target to $62 From $60, Maintains Overweight Rating. Jan. 18. MT. Transcript : Ionis Pharmaceuticals, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-10-2024 03:00 PM. Jan. 10. Analysts publish ratings and price targets on most stocks. ... The current price Ionis Pharmaceuticals (IONS) is trading at is $49.07, which is out of the analyst’s predicted range.Ionis (IONS) Q4 loss is narrower than expected ... the stock price fluctuated between a high of $19.99 and a low of $13.43. On Jan. 24, the telecom giant released its earnings for the year ...12 hours ago · The stock was sold at an average price of $49.54, for a total value of $105,272.50. ... Stifel Nicolaus increased their price target on Ionis Pharmaceuticals from $45.00 to $50.00 and gave the ... Find the latest dividend history for Ionis Pharmaceuticals, Inc. Common Stock (IONS) at Nasdaq.com.CARLSBAD, Calif., May 8, 2013 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today the pricing of an underwritten public offering of 9,000,000 shares of its common stock, offered at a price to the public of $19.00 per share. The gross proceeds to Isis from this offering are expected to be $171.0 million, before deducting the underwriting …Ionis Pharmaceuticals, Inc. Stock price Berne S.E. Equities IONS US4622221004 Biotechnology & Medical Research Market Closed - Berne S.E. Other stock markets. 12:00:02 2023-12-21 pm EST 5-day change ...Discover historical prices for IONS stock on Yahoo Finance. View daily, weekly or monthly format back to when Ionis Pharmaceuticals, Inc. stock was issued. Are you tired of spending endless hours searching for high-quality stock photos only to discover that they come with a hefty price tag? Look no further. In this article, we will ex...Ionis and partner Biogen brought Spinraza to market in 2016 as a treatment for a ... Key Insights Significantly high institutional ownership implies Ovid Therapeutics' stock price is sensitive to ...Ionis Pharmaceuticals, Inc. (ISI.FRA): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Ionis Pharmaceuticals, Inc. | Deutsche Boerse AG: ... JPMorgan Chase Adjusts Price Target on Ionis Pharmaceuticals to $55 From $52, Maintains Neutral Rating Feb. 01: MT ...Price T Rowe Associates Inc. MD now owns 4,255,074 shares of the company's stock valued at $215,265,000 after buying an additional 497,077 shares during the last quarter. Finally, BVF Inc. IL boosted its position in shares of Ionis Pharmaceuticals by 11.1% during the second quarter.Feb 14, 2024 · Get Ionis Pharmaceuticals Inc (IONS.OQ) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments Jan 31, 2024 · What was the 52-week low for Ionis Pharmaceuticals stock? The low in the last 52 weeks of Ionis Pharmaceuticals stock was 32.69. According to the current price, Ionis Pharmaceuticals is 157.20% ... 0333 336 5691. We're here whenever you need us, 24 hours a day, 7 days a week. Live Chat. Chat with one of our IONOS experts. UK web hosting packages for £1/year Includes domain Reliable – 99.9% uptime Storage and databases 24/7 support Free SSL » Get your project up and running now!Ionis stock price
Ionis Pharmaceuticals Inc stock price (IONS) NASDAQ: IONS. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Ionis Pharmaceuticals Inc stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting.The conversion rate will initially be 17.2902 shares of Ionis' common stock per $1,000 principal amount of notes (equivalent to an initial conversion price of approximately $57.84 per share of Ionis' common stock).View recent trades and share price information for Ionis Pharmaceuticals Inc Common Stock USD0.001 We don’t support this browser anymore. This means our website may not look and work as you ...The average twelve-month price prediction for Ionis Pharmaceuticals is $49.80 with a high price target of $70.00 and a low price target of $27.00. Learn more on IONS's analyst rating history. Dec 21, 2023 · These and other risks concerning Ionis' programs are described in additional detail in Ionis' annual report on Form 10-K for the year ended Dec. 31, 2022, and the most recent Form 10-Q quarterly filing, which are on file with the Securities and Exchange Commission. Copies of these and other documents are available from the Company. The stock price of Ionis Pharmaceuticals, a biotech company that specializes in discovering and developing RNA-targeted therapeutics, plunged 14% in yesterday’s trade to its five year low levels ...Ionis Pharmaceuticals Inc. analyst ratings, historical stock prices, earnings estimates & actuals. IONS updated stock price target summary. Real time Ionis Pharmaceuticals (IONS) stock price quote, stock graph, news & analysis. Find the latest Ionix Technology, Inc. (IINX) stock quote, history, news and other vital information to help you with your stock trading and investing.Jan 23, 2024 · Zacks Rank & A Key Pick. Ionis currently carries a Zacks Rank #2 (Buy). A better-ranked stock in the overall healthcare sector is CytomX Therapeutics (CTMX Quick Quote CTMX - Free Report) , which ... 0333 336 5691. We're here whenever you need us, 24 hours a day, 7 days a week. Live Chat. Chat with one of our IONOS experts. UK web hosting packages for £1/year Includes domain Reliable – 99.9% uptime Storage and databases 24/7 support Free SSL » Get your project up and running now!View live Ionis Pharmaceuticals, Inc. chart to track its stock's price action. Find market predictions, IONS financials and market news. See Ionis Pharmaceuticals, Inc. stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading strategy.IONIS PHARMACEUTICALS, INC. Payout Change None Price as of: FEB 23, 11:00 AM EST $45.36 +1.38 +0% Dividend (Fwd) $0.00 Yield (Fwd) Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price. ... Days Taken For Stock Price To RecoverDec 2, 2021 ... The stock price of Ionis Pharmaceuticals, a biotech company that specializes in discovering and developing RNA-targeted therapeutics, plunged 14 ...Ionis Pharmaceuticals appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its ...IONS Stock 12 Months Forecast. $59.92. (21.32% Upside) Based on 12 Wall Street analysts offering 12 month price targets for Ionis Pharmaceuticals in the last 3 months. The average price target is $59.92 with a high forecast of $85.00 and a low forecast of $37.00. The average price target represents a 21.32% change from the last price of $49.39. TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.comThe initial conversion price represents a premium of approximately 32.5% over the last reported sale price of $40.55 per share of Ionis' common stock on June 7, 2023.View the latest Ionis Pharmaceuticals Inc. (IONS) stock price, news, historical charts, analyst ratings and financial information from WSJ.Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced the appointment of Michael Yang, ... Analysts have a price target of 700 for the stock. Is Nvidia stock a buy now?Ionis Pharmaceuticals, Inc. reported strong Q4 earnings with a 34% YoY revenue increase. The stock price is down, is IONS a buy? Click for my IONS earnings …You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a br...About After Hours Quotes. Nasdaq provides market information on after hours trading daily from 4:15 p.m. ET to 3:30 p.m. ET on the following day. Tesla, Inc. Common Stock. $248.50 -2.99 -1.19%. Stock analysis for Ionis Pharmaceuticals Inc (IONS:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.The initial conversion price represents a premium of approximately 32.5% over the last reported sale price of $40.55 per share of Ionis' common stock on June 7, 2023.IONS support price is $49.07 and resistance is $50.89 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that IONS stock will trade within this expected range on the day.Jul 17, 2023 ... He has a buy rating and 29 price target on BBIO stock. ... 11/05/2023 Ionis Pharmaceuticals shows rising price performance, earning an upgrade to.Because of some negative drug trial data since January, Ionis’s stock price has fallen from over $60 per share to below $40 per share, closing on May 28 at $37.25.The initial conversion price represents a premium of approximately 32.5% over the last reported sale price of $40.55 per share of Ionis' common stock on June 7, 2023.Stock analysis for Ionis Pharmaceuticals Inc (ISIP:US) including stock price, stock chart, company news, key statistics, fundamentals and company profile. While the top- and bottom-line numbers for Ionis Pharmaceuticals ... The stock currently has a Zacks Rank ... it would cost him roughly $450 million. In a post on X, formerly Twitter, Grant ...When it comes to purchasing a new vehicle, finding the perfect car that meets all your requirements can be a daunting task. If you have your heart set on a Genesis GV70, you’ll wan...Because of some negative drug trial data since January, Ionis’s stock price has fallen from over $60 per share to below $40 per share, closing on May 28 at $37.25.Ionis Pharmaceuticals Stock Forecast. All Analysts Top Analysts Stock Price Forecast. The 14 analysts with 12-month price forecasts for IONS stock have an average target of 53.21, with a low estimate of 27 and a high estimate of 88. The average target predicts an increase of 19.76% from the current stock price of 44.43.Feb 2, 2024 · The 15 analysts with 12-month price forecasts for IONS stock have an average target of 51.93, with a low estimate of 27 and a high estimate of 88. The average target predicts an increase of 4.38% from the current stock price of 49.75. Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced positive topline results for the Phase 3 OASIS-HAE study of donidalorsen in people with hereditary angioedema (HAE). The trial met its primary endpoint of reduction in rate of angioedema attacks in patients treated with donidalorsen (80mg) via subcutaneous injection dosed every 4 weeks …Sep 26, 2023 ... On the stock market today, Ionis stock jumped 8.5% to close at 46.28 ... Stock Quotes · MarketSmith · Newsletters · How to Buy Stocks ·...Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced positive topline results for the Phase 3 OASIS-HAE study of donidalorsen in people with hereditary angioedema (HAE). …TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.comIonis’ stock has risen 18.8% in the past year against a decrease of 5.2% for the industry. Zacks Investment Research. Image Source: ... Ionis Pharmaceuticals, Inc. Price and Consensus.Find the latest Ionix Technology, Inc. (IINX) stock quote, history, news and other vital information to help you with your stock trading and investing.Stock quote Change Volume Today's Open Previous Close. Today's High Today's Low 52 Week High 52 Week Low. Stock Chart. Data Provided by Refinitiv. Minimum 15 minutes delayed. ©1989 - 2024 Ionis Pharmaceuticals ...12 hours ago · The stock was sold at an average price of $49.54, for a total value of $105,272.50. ... Stifel Nicolaus increased their price target on Ionis Pharmaceuticals from $45.00 to $50.00 and gave the ... 12 hours ago · The stock was sold at an average price of $49.54, for a total value of $105,272.50. ... Stifel Nicolaus increased their price target on Ionis Pharmaceuticals from $45.00 to $50.00 and gave the ... Feb 15, 2024 · Summary of all time highs, changes and price drops for Ionis Pharmaceuticals; Historical stock prices; Current Share Price: US$44.43: 52 Week High: US$54.44: 52 Week Low: Find the latest historical data for Ionis Pharmaceuticals, Inc. Common Stock (IONS) at Nasdaq.com. If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up t...4 days ago · Get Ionis Pharmaceuticals Inc (IONS.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments Ionis Pharmaceuticals appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its ...The stock price of Ionis Pharmaceuticals, a biotech company that specializes in discovering and developing RNA-targeted therapeutics, plunged 14% in yesterday’s …Ionis (IONS) incurs a wider-than-expected third-quarter loss. ... Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, ...Get the latest Ionis Pharmaceuticals Inc. (IONS) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a br...46.28. 2,684,400. *Close price adjusted for splits. **Close price adjusted for splits and dividend and/or capital gain distributions. Discover historical prices for IONS stock on Yahoo Finance. View daily, weekly or monthly formats back to when Ionis Pharmaceuticals, Inc. stock was issued.Ionis (IONS) reports positive phase III study results, ... Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, ...Ionis Pharmaceuticals (NASDAQ:IONS - Get Free Report) was upgraded by research analysts at StockNews.com from a "sell" rating to a "hold" rating in a report …Ionis Pharmaceuticals, Inc. Stock price Berne S.E. Equities IONS US4622221004 Biotechnology & Medical Research Market Closed - Berne S.E. Other stock markets. 12:00:02 2023-12-21 pm EST 5-day change ...View Ionis Pharmaceuticals, Inc. IONS stock quote prices, financial information, real-time forecasts, and company news from CNN.14.58. -0.41. -2.74%. Get Ionis Pharmaceuticals Inc (IONS:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.On eToro, you can buy $IONS or other stocks and pay ZERO commission! Follow Ionis Pharmaceuticals share price and get more information. Terms apply.IONS Stock 12 Months Forecast. $59.92. (21.32% Upside) Based on 12 Wall Street analysts offering 12 month price targets for Ionis Pharmaceuticals in the last 3 months. The average price target is $59.92 with a high forecast of $85.00 and a low forecast of $37.00. The average price target represents a 21.32% change from the last price of $49.39. Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you...What is the Ionis Pharmaceuticals stock forecast? · Ionis Pharmaceuticals stock prediction for 1 year from now: $ 28.57 (-37.02%) · Ionis Pharmaceuticals stock ....Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins an...4 days ago · Ionis Pharmaceuticals Insider Sold Shares Worth $1,160,303, According to a Recent SEC Filing. Feb. 05. MT. JPMorgan Chase Adjusts Price Target on Ionis Pharmaceuticals to $55 From $52, Maintains Neutral Rating. Feb. 01. MT. Ionis Pharmaceuticals Insider Sold Shares Worth $333,788, According to a Recent SEC Filing. Find the latest Puma Biotechnology, Inc. (PBYI) stock quote, history, news and other vital information to help you with your stock trading and investing.Ionis Pharmaceuticals, Inc. Common Stock (IONS) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets. Find the latest historical data for Ionis Pharmaceuticals, Inc. Common Stock (IONS) at Nasdaq.com. Ionis share price is down 21% year on year, falling from $66 to $52. In March '19, the stock had traded at all-time highs of $85.. Colton dixon build a boat lyrics